Jackson E. is a seasoned biotechnology professional with extensive experience in analytical development and formulation within the pharmaceutical industry. Currently serving as the Director and Product Technical Lead at Intellia Therapeutics, Inc., since January 2022, Jackson previously held roles as Principal Scientist at ReCode Therapeutics and at Intellia Therapeutics, where significant contributions were made in mRNA and LNP characterization, method development, and tech transfers. Prior experience includes a role as Senior Scientist at Vedantra Pharmaceuticals, focusing on vaccine and immuno-oncology formulations, and a doctoral candidacy at Ecole Polytechnique Federale de Lausanne, researching immune cell interactions. Jackson holds a Ph.D. in Biotechnology from EPFL and a Bachelor's degree in Biomedical Engineering with a minor in Biology from The University of Texas at Austin.
This person is not in any teams
This person is not in any offices